Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

bmiMD vs Tyde Wellness

bmiMD
Graded #26

Higher grade

vs+4.200000000000003
Tyde Wellness
Graded #39

Lower grade

The verdict

bmiMD takes it — 84/100 to 79.8/100.

bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the cheapest both-molecule pairings ($99/$139), nationwide — but not LegitScript-listed.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuebmiMD +8
94
86
Dose & formulationTyde Wellness +3
80
83
Clinical oversightTyde Wellness +10
79
89
Labs & monitoringbmiMD +24
78
54
FulfillmentTyde Wellness +5
86
91
Contract termsbmiMD +22
83
61
bmiMD · left barTyde Wellness · right bar

The numbers

MetricbmiMDTyde Wellness
WeighScore84/10079.8/100
GradeBC+
Scorecard rank#26#39
Semaglutide$99/mo$149/mo (microdose tier, all doses, compounded)
Tirzepatide$139/mo$249/mo (microdose tier, all doses, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
bmiMD

Graded #26 · B

Strengths

  • $99 sema / $139 tirz
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Injection-only
  • Thin oversight/monitoring detail
Tyde Wellness

Graded #39 · C+

Strengths

  • All 50 states served (full list published)
  • Transparent pricing: semaglutide from $149/mo, tirzepatide from $249/mo
  • LegitScript Certified with a verification link
  • Five named 503A pharmacy partners with addresses: Belmar (CO), Casa (TX), Olympia (FL), Red Rock (UT), Beaker (TX)
  • Free consultation; cancel-anytime subscription with no long-term commitment

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic)
  • Tirzepatide priced higher than competitors offering $200-$249/mo
  • Corporate address and medical director not publicly disclosed
  • No NABP .pharmacy seal visible

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard